Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection

Archives of Ophthalmology

Volumn 121, Issue 5, 2003, Pages 735-737

  Kim, Judy E ^a   Perkins, Stephen L ^b   Harris, Gerald J ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; KETOCONAZOLE; METHYLPREDNISOLONE ACETATE; PREDNISOLONE ACETATE; VORICONAZOLE;

ABSCESS; AGED; ARTICLE; ASPERGILLUS FUMIGATUS; CASE REPORT; CLINICAL FEATURE; CONJUNCTIVA; DISEASE COURSE; DRUG BLOOD LEVEL; FEMALE; HUMAN; PRIORITY JOURNAL; RETINA DETACHMENT; SCLERA BUCKLING PROCEDURE; SCLERITIS; TREATMENT OUTCOME; VITRECTOMY;

ABSCESS; AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; EYE INFECTIONS, FUNGAL; FEMALE; HUMANS; ORBITAL DISEASES; PYRIMIDINES; SCLERAL BUCKLING; SCLERITIS; SURGICAL WOUND INFECTION; TRIAZOLES;

EID: 0037991477     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.121.5.735     Document Type: Article

References (9)

1. Murphy M, Bernard EM, Ishimaru T, Armstrong D. Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 1997;41:696-698.
2. McGinnis MR, Pasarell L, Sutton DA, et al. In vitro evaluation of voriconazole against some clinically important fungi. Antimicrob Agents Chemother. 1997;41:1832-1834.
3. Johnson EM, Szekely A, Warnock DW. In vitro activity of voriconazole, itraconazole, and amphotericin B against filamentous fungi. J Antimicrob Chemother. 1998;42:741-745.
4. Ghannoum MA, Kuhn DM. Voriconazole: better chances for patients with invasive mycosis. Eur J Med Res. 2002;7:242-256.
5. Denning DW, Ribaud P, Milpied N, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis. 2002;34:563-571.
6. Walsh TJ, Pappas P, Winston DJ, et al. Vori-conazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002;346:225-234.
7. Reis A, Sundmacher R, Tintelnot K, Agostini H, Jensen HE, Althaus C. Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole. Br J Ophthalmol. 2000;84:932-933.
8. Borkowski LM, Lyon AT, Jampol LM, Weinberg DV. Endogenous Fusarium endophthalmitis [JARVO abstract]. Invest Ophthal Vis Sci. 2000; 41:S353.
9. Garbino J, Ondrusova A, Baligvo E, Lew D, Bouchuiguir-Wafa K, Rhoner P. Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. Scand J Infect Dis. 2002;34: 701-703.